The DOI matches its Crossref record.
Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors
Abstract
A series of 43 adrenocortical tumors was analyzed using nine histologic features. Mitotic activity, especially with atypical forms, and venous invasion correlated best with metastasizing or recurring tumors; however, no single criterion was useful alone. The combination of the following nine criteria was most useful in distinguishing malignant from benign tumors: nuclear grade III or IV; mitotic rate greater than 5/50 high-power fields; atypical mitoses; clear cells comprising 25% or less of the tumor; a diffuse architecture; microscopic necrosis; and invasion of venous, sinusoidal, and capsular structures. None of the 24 tumors with two or less of these criteria metastasized or recurred, while all but one of the 19 tumors with four or more of these criteria either recurred or metastasized.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the initial study by Weiss, the features with the strongest association to outcome were the mitotic rate >5/50 high powered field, atypical mitoses, and venous invasion (111) and in the second study by Weiss in 1989 the strongest association with patient outcome was the mitotic rate (112).”
From Adrenal incidentaloma (2020) · cites this paper as [111]
In the citing paper
“The most widely used histological scoring system is the Weiss score (Table 4) based on 9 histological parameters (scored as 0 if absent and 1 if present) (110,111).”
From Adrenal incidentaloma (2020) · cites this paper as [111]
Citations
Cited by
Sorted by citations
Items 201–300 of 921
Adrenocortical Tumors in Brazilian Children: Immunohistochemical Markers and Prognostic Factors
Sbragia, L., de Oliveira-Filho, A. G., Vassallo, J., et al. (2005) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2005-129-1127-atibci · Cited by 44
Agrons, G. A., Lonergan, G. J., Dickey, G. E., et al. (1999) · Radiographics · doi:10.1148/radiographics.19.4.g99jl14989 · Cited by 44
Altered Expression of novH Is Associated with Human Adrenocortical Tumorigenesis
Martinerie, C., Gicquel, C., Louvel, A., Laurent, M., Schofield, P. N., & Bouc, Y. L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7718 · Cited by 49
Basile, V., Puglisi, S., Calabrese, A., Pia, A. R., Perotti, P., Berruti, A., Reimondo, G., & Terzolo, M. (2020) · Cancers · doi:10.3390/cancers12092615 · Cited by 44
Kammula, U. S., White, D. E., & Rosenberg, S. A. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980815)83:4 · Cited by 200
Klein, F. A., Kay, S., Ratliff, J. E., White, F. K. H., & Newsome, H. H. (1985) · Journal of Urology · doi:10.1016/s0022-5347(17)47495-7 · Cited by 43
Yen, S., Hsieh, C., & MacMahon, B. (1987) · Cancer · doi:10.1002/1097-0142(19870615)59:12 · Cited by 60
Gene expression profiling in adrenocortical neoplasia
Assié, G., Giordano, T. J., & Bertherat, J. Y. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.044 · Cited by 41
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane
D’Avolio, A., Francia, S. D., Basile, V., Cusato, J., Martino, F., Pirro, E., Piccione, F. M., Ardito, A., Zaggia, B., Volante, M., et al. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283606cb2 · Cited by 42
3β-hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma
Konosu‐Fukaya, S., Nakamura, Y., Satoh, F., Felizola, S. J. A., Maekawa, T., Ono, Y., Morimoto, R., Ise, K., Takeda, K.-I., Katsu, K., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.10.008 · Cited by 43
Adrenocortical oncocytic neoplasm: A systematic review
Kanitra, J. J., Hardaway, J. C., Soleimani, T., Koehler, T. J., McLeod, M. K., & Kavuturu, S. (2018) · Surgery · doi:10.1016/j.surg.2018.04.044 · Cited by 43
Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era
Mohan, D. R., Lerário, A. M., & Hammer, G. D. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00197 · Cited by 42
Histopathological classification of adrenal tumours
Saeger, W. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.0300s3058.x · Cited by 42
Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors
Pinheiro, C. M., Granja, S., Longatto‐Filho, A., Faria, A. M., Fragoso, M. C. B. V., Lovisolo, S. M., Lerário, A. M., Almeida, M. Q., Baltazar, F., & Zerbini, M. C. N. (2015) · Oncotarget · doi:10.18632/oncotarget.5623 · Cited by 41
A CDK2 activity signature predicts outcome in CDK2-low cancers
McCurdy, S. R., Pacal, M., Ahmad, M. A. E.-R., & Bremner, R. (2016) · Oncogene · doi:10.1038/onc.2016.409 · Cited by 42
Martins-Filho, S. N., Almeida, M. Q., Soares, I. C., Wakamatsu, A., Alves, V. A. F., Fragoso, M. C. B. V., & Zerbini, M. C. N. (2021) · Endocrine Pathology · doi:10.1007/s12022-020-09654-x · Cited by 42
Virilising adrenocortical tumours in children
Bonfig, W., Bittmann, I., Bechtold, S. M., Kammer, B., Noelle, V., Arleth, S., Raile, K., & Schwarz, H. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-003-1230-y · Cited by 42
A case of adrenocortical carcinoma associated with recurrence after laparoscopic surgery
Iino, K., Oki, Y., & Sasano, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01036.x · Cited by 41
Feminizing adreno-cortical carcinomas in male adults. A dire prognosis
Moreno, S., Guillermo, M., Decoulx, M., Dewailly, D., Bresson, R., & Proye, C. (2006) · Annales d Endocrinologie · doi:10.1016/s0003-4266(06)72537-9 · Cited by 40
Diagnostic efficacy of 18F-FDG PET/CT in patients with adrenal incidentaloma
Akkuş, G., Güney, İ. B., Ok, F., Evran, M., İzol, V., Erdoğan, Ş., Bayazıt, Y., Sert, M., & Tetıker, T. (2019) · Endocrine Connections · doi:10.1530/ec-19-0204 · Cited by 42
Clinical characteristics of adrenocortical tumors in children
Chen, Q., Su, Z., Li, Y., Ma, H., Chen, H.-S., & Du, M. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.175 · Cited by 40
Adrenal cortical tumors in children: factors associated with poor outcome
Klein, J. D., Turner, C. G. B., Gray, F. L., Yu, D. C., Kozakewich, H. P., Pérez‐Atayde, A. R., Voss, S. D., Zurakowski, D., Shamberger, R. C., & Weldon, C. B. (2011) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2011.03.052 · Cited by 39
Surgical Management of Adrenocortical Carcinoma
Datta, J., & Roses, R. E. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.08.011 · Cited by 38
Primary Adrenal Causes of Cushingʼs Syndrome; Diagnosis and Surgical Management
Perry, R. R., Nieman, L. K., Cutler, G. B., et al. (1989) · Annals of Surgery · doi:10.1097/00000658-198907000-00010 · Cited by 39
Khorram‐Manesh, A., Ahlman, H., Jansson, S. K. G., et al. (2002) · Endocrine Pathology · doi:10.1385/ep:13:2:099 · Cited by 39
Leboulleux, S., Gaston, V., Boulle, N., Bouc, Y. L., & Gicquel, C. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440163 · Cited by 39
Surgical treatment of adrenal carcinoma
Gaujoux, S., Weinandt, M., Bonnet, S., Reslinger, V., Bertherat, J. Y., & Dousset, B. E. (2017) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2017.06.010 · Cited by 38
Primary adrenocortical sarcomatoid carcinoma: case report and review of literature
Stürm, N., Moulaï, N., Laverrière, M., Chabre, O., Descotes, J., & Brambilla, E. M. (2007) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-007-0536-y · Cited by 38
Pohlink, C., Tannapfel, A., Eichfeld, U., Schmidt, F., Führer, D., Paschke, R., & Koch, C. A. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347480 · Cited by 38
Kitching, P. A., Patel, V., & Harach, H. R. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.2.151 · Cited by 38
Martino, M. C. D., van Koetsveld, P. M., Feelders, R. A., de Herder, W. W., Dogan, F., Janssen, J. A. M. J. L., Bruinink, D. H. O., Pivonello, C., Waaijers, A. M., Colao, A., et al. (2019) · Endocrine · doi:10.1007/s12020-019-01869-1 · Cited by 39
Lau, S. K., Chu, P. G., & Weiss, L. M. (2010) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2010.02.005 · Cited by 37
Self-citationAdrenal gland and other paraganglia
(2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06969-4.00011-8 · Cited by 37
Jakobsen, A.-M., Ahlman, H. K., Kölby, L., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600924 · Cited by 37
A population-based case-control study of childhood leukemia in shanghai
Shu, X. O., Gao, Y. T., Tu, J., Zheng, W., Brinton, L. A., Linet, M. S., & Fraumeni, J. F. (1988) · Cancer · doi:10.1002/1097-0142(19880801)62:3 · Cited by 291
Adrenocortical carcinoma: The influence of large vessel extension
Turbendian, H. K., Strong, V. E. M., Hsu, M., Ghossein, R. A., & Fahey, T. J. (2010) · Surgery · doi:10.1016/j.surg.2010.09.024 · Cited by 36
Giordano, T. J., Berney, D. M., de Krijger, R. R., et al. (2020) · Human Pathology · doi:10.1016/j.humpath.2020.10.001 · Cited by 36
Steroidogenic acute regulatory protein mRNA expression in adrenal tumours
Zenkert, S., Schubert, B., Faßnacht, M., Beuschlein, F., Allolio, B., & Reincke, M. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420294 · Cited by 36
Adrenocortical Cancer Treatment
Patalano, A., Brancato, V., & Mantero, F. (2009) · Hormone Research in Paediatrics · doi:10.1159/000178049 · Cited by 34
Dysregulation of microRNAs in adrenocortical tumors
Singh, P., Soon, P. S. H., Feige, J., Chabre, O., Zhao, J., Cherradi, N., Lalli, E., & Sidhu, S. B. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.041 · Cited by 35
The molecular basis of adrenocortical cancer
Lehmann, T. P., & Wrzesiński, T. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.02.009 · Cited by 34
Mastellaro, M. J., Seidinger, A. L., Kang, G., Abrahão, R., MIRANDA, E. C. M., Pounds, S. B., Cardinalli, I. A., Aguiar, S. S., de Figueiredo, B. C., Galindo, C. R., et al. (2017) · Cancer · doi:10.1002/cncr.30703 · Cited by 36
Parise, I. Z. S., Parise, G. A., de Noronha, L., Surakhy, M., Woiski, T. D., Silva, D. B., Costa, T. E.-J. B., Del-Valle, M. H. C. P., Komechen, H., Rosati, R., et al. (2019) · Cancers · doi:10.3390/cancers11111730 · Cited by 37
Ozsari, L., Kutahyalioglu, M., Elsayes, K. M., Vicens, R., Sircar, K., Jazaerly, T., Waguespack, S. G., Busaidy, N. L., Cabanillas, M. E., Dadu, R., et al. (2015) · Endocrine · doi:10.1007/s12020-015-0694-7 · Cited by 35
Adrenocortical tumors: results of treatment and study of Weiss's score as a prognostic factor
Lucón, A. M., Pereira, M. A. A., Mendonca, B. B., Zerbini, M. C. N., Saldanha, L. B., & Arap, S. (2002) · Revista do Hospital das Clínicas · doi:10.1590/s0041-87812002000600002 · Cited by 35
Rodgers, S. E., Evans, D. B., Lee, J. E., & Perrier, N. D. (2006) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2006.05.005 · Cited by 36
Practical Considerations in the Evaluation and Management of Adrenocortical Cancer
Balasubramaniam, S., & Fojo, T. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.10.011 · Cited by 34
Pediatric adrenocortical tumor – review and management update
Balderrama-Brondani, V., & Fragoso, M. C. B. V. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000540 · Cited by 35
Classification of adrenal cortical tumors: What limits for the pathological approach?
Tissier, F. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.011 · Cited by 34
Fine-Needle Aspiration of Adrenal Cortical Carcinoma
Ren, R., Guo, M., Sneige, N., Moran, C. A., & Gong, Y. (2006) · American Journal of Clinical Pathology · doi:10.1309/aqfeb5wemu41n9k1 · Cited by 34
Weiss criteria in large adrenocortical tumors: A validation study
Jain, M. K., Kapoor, S., Mishra, A. K., et al. (2010) · Indian Journal of Pathology and Microbiology · doi:10.4103/0377-4929.64325 · Cited by 34
BENCSIK, Z., Szabolcs, I., Góth, M., VÖRÖS, A., Kaszás, I., Gönczi, J., Kovács, L., Dohán, O., & Szilägyi, G. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb00889.x · Cited by 33
Papotti, M., Duregon, E., Volante, M., & McNicol, A. M. (2014) · Endocrine Pathology · doi:10.1007/s12022-013-9291-6 · Cited by 33
“This proposal (the Weiss score) was a major advance in adrenal cortical cancer pathology and still represents—in its original proposal [1, 2] or after minor modifications [3]—a milestone in this field.”
BackgroundUpdate on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies
Lerário, A. M., Mohan, D. R., & Hammer, G. D. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac012 · Cited by 36
Lee, C. W., Salem, A. I., Schneider, D. F., LEVERSON, G. E., Tran, T. B., Poultsides, G. A., Postlewait, L. M., Maithel, S. K., Wang, T. S., Hatzaras, I. S., et al. (2016) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-016-3262-4 · Cited by 33
Gao, X., Yamazaki, Y., Tezuka, Y., Onodera, Y., Ogata, H., Omata, K., Morimoto, R., Nakamura, Y., Satoh, F., & Sasano, H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105434 · Cited by 32
Morimoto, R., Satoh, F., Murakami, O., et al. (2007) · Peptides · doi:10.1016/j.peptides.2007.06.025 · Cited by 33
The Glucocorticoid Receptor Is Overexpressed in Malignant Adrenocortical Tumors
Tacon, L. J., Soon, P. S. H., Gill, A. J., Chou, A. S. Y., Clarkson, A., Botling, J., Stalberg, P. L. H., Skogseid, B. M., Robinson, B. G., Sidhu, S. B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0546 · Cited by 33
GUPTA, D. K. D., Shidham, V. B., Holden, J. A., & Layfield, L. J. (2001) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200109000-00004 · Cited by 33
Yamazaki, Y., Omata, K., Tezuka, Y., Ono, Y., Morimoto, R., Adachi, Y., Ise, K., Nakamura, Y., Gómez-Sánchez, C. E., Shibahara, Y., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10907 · Cited by 33
Management of Massive Retroperitoneal Hemorrhage from an Adrenal Tumor.
Hendrickson, R. J., Katzman, P. J., Queiroz, R., Sitzmann, J. V., & Koniaris, L. G. (2001) · Endocrine Journal · doi:10.1507/endocrj.48.691 · Cited by 33
Adrenal incidentaloma: Surgical update
Guerrieri, M., de Sanctis, A., Crosta, F., Arnaldi, G., Boscaro, M., Lezoche, G., & Campagnacci, R. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347425 · Cited by 33
Barbosa, A. S., Giacaglia, L. R., Martin, R. M., Mendonca, B. B., & Lin, C. J. (2004) · BMC Endocrine Disorders · doi:10.1186/1472-6823-4-3 · Cited by 33
Barzilay, J. I., & Pazianos, A. G. (1989) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)01828-0 · Cited by 35
Inoue, K., Yamazaki, Y., Kitamoto, T., Hirose, R., Saito, J., Omura, M., Sasano, H., & Nishikawa, T. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00738 · Cited by 32
Enriquez, M. L., Lal, P., Ziober, A. F., Wang, L., Tomaszewski, J. E., & Bing, Z. (2012) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31823605e7 · Cited by 31
Oncocytic Adrenal Cortical Carcinosarcoma With Pleomorphic Rhabdomyosarcomatous Metastases
Thway, K., Olmos, D., Shah, C. M., Flora, R., SHIPLEY, J. M., & Fisher, C. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31824517d9 · Cited by 32
Sigurjónsdóttir, H. Á., Gronowitz, M., Andersson, O., Eggertsen, R., Herlitz, H., Sakinis, A., Wängberg, B., & Johannsson, G. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-17 · Cited by 32
Klibanski, A., Stephen, A., Greene, M., Blake, M., & Wu, C.-L. (2006) · New England Journal of Medicine · doi:10.1056/nejmcpc069027 · Cited by 22
Pinto, E. M., Galindo, C. R., Choi, J. K., Pounds, S. B., Liu, Z., Neale, G. A. M., Finkelstein, D., Hicks, J. M., Pappo, A. S., de Figueiredo, B. C., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2738 · Cited by 35
Makino, S., Oda, S., Saka, T., 安川, 元., Komatsu, F., & Sasano, H. (2001) · Endocrine Journal · doi:10.1507/endocrj.48.103 · Cited by 32
Advances in translational research of the rare cancer type adrenocortical carcinoma
Ghosh, C., Hu, J., & Kebebew, E. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00623-0 · Cited by 34
Aldosterone-Secreting Adrenal Cortical Carcinoma. A Case Report and Review of the Literature
Griffin, A. C., Kelz, R. K., & LiVolsi, V. A. (2014) · Endocrine Pathology · doi:10.1007/s12022-014-9307-x · Cited by 31
How to Differentiate Benign from Malignant Adrenocortical Tumors?
Viëtor, C. L., Creemers, S. G., van Kemenade, F. J., van Ginhoven, T. M., Hofland, L. J., & Feelders, R. A. (2021) · Cancers · doi:10.3390/cancers13174383 · Cited by 33
Adrenocortical carcinoma with inferior vena cava tumor thrombus
Laan, D. V., Thiels, C. A., Glasgow, A. E., Wise, K. B., Thompson, G. B., Richards, M. L., Farley, D. R., Truty, M. J., & McKenzie, T. J. (2016) · Surgery · doi:10.1016/j.surg.2016.07.040 · Cited by 30
Yang, Y., Xiao, M., Song, Y., Tang, Y., Luo, T., Yang, S., He, W., Cheng, Q., Ma, L., Zhang, Y., et al. (2019) · Endocrine · doi:10.1007/s12020-019-02022-8 · Cited by 31
Innervation of human adrenal gland and adrenal cortical lesions
Li, Q., Johansson, H., & Grimelius, L. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050444 · Cited by 31
The human adrenal cortex: growth control and disorders
Lotfi, C. F. P., Kremer, J. L., Passaia, B. D. S., & Cavalcante, I. P. (2018) · Clinics · doi:10.6061/clinics/2018/e473s · Cited by 31
Pathophysiology, Evaluation, and Medical Management of Adrenal Disorders
Kutikov, A., Crispen, P. L., & Uzzo, R. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00057-8 · Cited by 31
Experience with the surgical treatment of adrenal cortical carcinoma
Meyer, A. A., Niemann, U., & Behrend, M. (2004) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.01.021 · Cited by 30
Aktuelle TNM-Klassifikationssysteme für das Nebennierenkarzinom
Faßnacht, M., Wittekind, C., & Allolio, B. (2010) · Der Pathologe · doi:10.1007/s00292-010-1306-1 · Cited by 29
Chambre, C., McMurray, E. M., Baudry, C., Lataud, M., Guignat, L., Gaujoux, S., Lahlou, N., Guibourdenche, J., Tissier, F., Sibony, M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0036 · Cited by 29
Cancer of the Endocrine System
Lal, G., O’Dorisio, T. M., McDougall, I. R., & Weigel, R. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50079-8 · Cited by 29
Sasano, H., Sato, S., Yajima, A., et al. (1997) · Pathology International · doi:10.1111/j.1440-1827.1997.tb04529.x · Cited by 29
Bottazzi, E. C., Gambardella, C., Mongardini, F. M., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216925 · Cited by 28
Endoscopic adrenalectomy in large adrenal tumors
Asari, R., Koperek, O., & Niederle, B. (2012) · Surgery · doi:10.1016/j.surg.2012.02.003 · Cited by 27
Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors
Nielsen, H. M., How‐Kit, A., Guérin, C., Castinetti, F., Vollan, H. K. M., Micco, C. D., Daunay, A., Taïeb, D., Loo, P. V., Besse, C., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0086 · Cited by 28
Medical Approaches in Adrenocortical Carcinoma
Paragliola, R. M., Corsello, A., Locantore, P., Papi, G., Pontecorvi, A., & Corsello, S. M. (2020) · Biomedicines · doi:10.3390/biomedicines8120551 · Cited by 29
Yokoyama, H., Adachi, T., Tsubouchi, K., et al. (2013) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.229.267 · Cited by 28
Kazumori, A. R. A. I., Muro, H., Suzuki, M., et al. (2000) · Pathology International · doi:10.1046/j.1440-1827.2000.01029.x · Cited by 28
Morimoto, R., Satani, N., Iwakura, Y., Ono, Y., Kudo, M., Nezu, M., Omata, K., Tezuka, Y., Seiji, K., Ota, H., et al. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.100 · Cited by 28
Molecular Imaging in the Management of Adrenocortical Cancer
Wong, K. K., Miller, B. S., Viglianti, B. L., Dwamena, B. A., Gauger, P. G., Cook, G., Colletti, P. M., Rubello, D., & Gross, M. D. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001112 · Cited by 29
Rosenberg, D., Groussin, L., Jullian, E. H., Perlemoine, K., Medjane, S., Louvel, A., BERTAGNA, X. Y., & Bertherat, J. Y. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030070 · Cited by 28
Histopathological Diagnosis and Prognostic Factors in Adrenocortical Carcinoma
Aiba, M., & Fujibayashi, M. (2005) · Endocrine Pathology · doi:10.1385/ep:16:1:013 · Cited by 27
Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma
Haak, H. R., Cornelisse, C. J., Hermans, J., Cobben, L., & Fleuren, G. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.304 · Cited by 28
McNicol, A. M. (2008) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2008-132-1263-lotac · Cited by 28
Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors
Martino, M. C. D., Feelders, R. A., de Herder, W. W., van Koetsveld, P. M., Dogan, F., Janssen, J. A. M. J. L., Waaijers, A. M., Pivonello, C., Lamberts, S. W. J., Colao, A., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0112 · Cited by 27
Functional Oncocytic Adrenocortical Carcinoma
Ali, A. E., & Raphael, S. J. (2007) · Endocrine Pathology · doi:10.1007/s12022-007-9000-4 · Cited by 27
Morimoto, R., Satoh, F., Murakami, O., Hirose, T., Totsune, K., Imai, Y., Arai, Y., SUZUKI, T. A., Sasano, H., Ito, S., et al. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0103 · Cited by 27
Gicquel, C., Baudin, É., Bouc, Y. L., & Schlumberger, M. J. (1997) · Annals of Oncology · doi:10.1023/a:1008257530919 · Cited by 27
Metadata
- Authors
- Weiss, L. M.
- Corresponding author
- Weiss, Lawrence M.
- ORCID
- Weiss, Lawrence M.
- Venue
- The American Journal of Surgical Pathology
- Published
- 1984-03
- Volume
- 8
- Issue
- 3
- Pages
- 163-170
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W2039836243
- Cited by
- 920
- References
- 0
- Citations by year
- 2026: 21 · 2025: 19 · 2024: 24 · 2023: 23 · 2022: 31 · 2021: 38 · 2020: 36 · 2019: 24 · 2018: 32 · 2017: 28 · 2016: 39 · 2015: 44 · 2014: 50 · 2013: 29 · 2012: 26
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Surgical Pathology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Keywords
- adrenocortical tumors, adrenal metastasis, tumor recurrence, histologic grading, mitotic activity, atypical mitoses, venous invasion, capsular invasion, clear cells, tumor differentiation, adrenocortical carcinoma
- MeSH terms
- Adenoma, Adrenal Cortex Neoplasms, Adult, Aged, Carcinoma, Female, Humans, Male, Middle Aged, Mitosis, Necrosis, Neoplasm Recurrence, Local, Prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review